JP2012519668A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012519668A5 JP2012519668A5 JP2011552459A JP2011552459A JP2012519668A5 JP 2012519668 A5 JP2012519668 A5 JP 2012519668A5 JP 2011552459 A JP2011552459 A JP 2011552459A JP 2011552459 A JP2011552459 A JP 2011552459A JP 2012519668 A5 JP2012519668 A5 JP 2012519668A5
- Authority
- JP
- Japan
- Prior art keywords
- lower alkyl
- phenyl
- substituted
- methyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *c1cc(Nc2nccc(*)n2)c(*)cc1 Chemical compound *c1cc(Nc2nccc(*)n2)c(*)cc1 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09154507 | 2009-03-06 | ||
| EP09154507.9 | 2009-03-06 | ||
| EP09166437.5 | 2009-07-27 | ||
| EP09166437 | 2009-07-27 | ||
| PCT/EP2010/052797 WO2010100248A1 (en) | 2009-03-06 | 2010-03-05 | Use of pyrimidylaminobenzamide derivatives for the treatment of disorders mediated by the leucine zipper- and sterile alpha motif-containing kinase (zak) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012519668A JP2012519668A (ja) | 2012-08-30 |
| JP2012519668A5 true JP2012519668A5 (https=) | 2013-04-18 |
Family
ID=42115422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011552459A Pending JP2012519668A (ja) | 2009-03-06 | 2010-03-05 | ロイシンジッパーおよび滅菌αモチーフを含有するキナーゼ（ＺＡＫ）によって媒介される障害を治療するためのピリミジルアミノベンズアミド誘導体の使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20120015968A1 (https=) |
| EP (1) | EP2403492A1 (https=) |
| JP (1) | JP2012519668A (https=) |
| KR (1) | KR20110132439A (https=) |
| CN (1) | CN102341102A (https=) |
| AU (1) | AU2010220262B2 (https=) |
| BR (1) | BRPI1013366A2 (https=) |
| CA (1) | CA2753637A1 (https=) |
| MX (1) | MX2011009310A (https=) |
| RU (1) | RU2011140404A (https=) |
| WO (1) | WO2010100248A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6697311B2 (ja) * | 2016-04-01 | 2020-05-20 | ショーワグローブ株式会社 | 手袋 |
| CN108117553B (zh) * | 2016-11-30 | 2019-08-16 | 暨南大学 | 炔苯基苯磺酰胺类选择性zak抑制剂及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7429599B2 (en) * | 2000-12-06 | 2008-09-30 | Signal Pharmaceuticals, Llc | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| WO2004002963A1 (ja) | 2002-06-28 | 2004-01-08 | Nippon Shinyaku Co., Ltd. | アミド誘導体及び医薬 |
| GB0215676D0 (en) | 2002-07-05 | 2002-08-14 | Novartis Ag | Organic compounds |
| CA2552759A1 (en) * | 2004-01-22 | 2005-08-04 | Novartis Ag | Combination of organic compounds |
| WO2005118833A2 (en) * | 2004-06-01 | 2005-12-15 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with sterile-alpha motif and leucine zipper containing kinase (zak) |
| GT200600315A (es) | 2005-07-20 | 2007-03-19 | Formas cristalinas de 4-metilo-n-[3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo]-3-(4-pyridina-3-ilo-pirimidina-2-iloamino)-benzamida | |
| GT200600316A (es) | 2005-07-20 | 2007-04-02 | Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida. | |
| RU2008108911A (ru) * | 2005-08-11 | 2009-09-20 | Новартис АГ (CH) | Комбинация органических соединений |
| WO2007051862A1 (en) * | 2005-11-07 | 2007-05-10 | Novartis Ag | Combination of organic compounds |
| WO2008058037A1 (en) * | 2006-11-03 | 2008-05-15 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| AU2007316558A1 (en) * | 2006-11-09 | 2008-05-15 | Abbott Gmbh & Co. Kg | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
| CN101185627B (zh) * | 2007-12-14 | 2011-04-20 | 山东蓝金生物工程有限公司 | 一种治疗实体肿瘤的尼罗替尼缓释植入剂 |
-
2010
- 2010-03-05 MX MX2011009310A patent/MX2011009310A/es not_active Application Discontinuation
- 2010-03-05 CA CA2753637A patent/CA2753637A1/en not_active Abandoned
- 2010-03-05 WO PCT/EP2010/052797 patent/WO2010100248A1/en not_active Ceased
- 2010-03-05 RU RU2011140404/04A patent/RU2011140404A/ru not_active Application Discontinuation
- 2010-03-05 EP EP10706268A patent/EP2403492A1/en not_active Withdrawn
- 2010-03-05 US US13/254,261 patent/US20120015968A1/en not_active Abandoned
- 2010-03-05 BR BRPI1013366A patent/BRPI1013366A2/pt not_active IP Right Cessation
- 2010-03-05 CN CN2010800105713A patent/CN102341102A/zh active Pending
- 2010-03-05 AU AU2010220262A patent/AU2010220262B2/en not_active Ceased
- 2010-03-05 KR KR1020117023373A patent/KR20110132439A/ko not_active Withdrawn
- 2010-03-05 JP JP2011552459A patent/JP2012519668A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| USRE49556E1 (en) | Compounds and compositions as protein kinase inhibitors | |
| US10774065B2 (en) | 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2 | |
| US9815813B2 (en) | 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2 | |
| AU2014233411B2 (en) | 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities | |
| AU2014233414B2 (en) | N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities | |
| JP2011530607A5 (https=) | ||
| WO2014145023A1 (en) | 1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities | |
| AR079029A1 (es) | Derivados de pirimidil-amino-benzamida para tratar trastornos proliferativos y otras condiciones patologicas mediadas por la actividad de cinasa de bcr-abl, c-kit, ddr1, ddr2 o pdgf-r | |
| WO2014145029A2 (en) | N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities | |
| RU2012120901A (ru) | Способ лечения пролиферативных расстройств и других патологических состояний, опосредованных действием киназ bcr-abl, c-kit, ddr1, ddr2 или pdgf-r | |
| US20130096149A1 (en) | Heteroaryl compounds and compositions as protein kinase inhibitors | |
| MY148375A (en) | Delta and epsilon crystal forms of imatinib mesylate | |
| RU2012147511A (ru) | Применение ингибиторов c-src в комбинации с пиримидиламинобензамидом для лечения лейкоза | |
| JP2016525104A5 (https=) | ||
| KR20220028075A (ko) | 티로신 키나제 비-수용체 1 (tnk1) 억제제 및 그의 용도 | |
| RU2011105059A (ru) | Применение производных пиримидиламинобензамида для лечения фиброза | |
| JP2009537606A5 (https=) | ||
| CN110402141A (zh) | Axl抑制剂和EGFR酪氨酸激酶抑制剂的联合疗法 | |
| JP2012519668A5 (https=) | ||
| JP2003516994A5 (https=) | ||
| RU2008127264A (ru) | Производные пиримидиламинобензамида, предназначенные для лечения нейрофиброматоза | |
| RU2007132255A (ru) | Применение пиримидиламинобензамидов для лечения заболеваний, чувствительных к модуляции активности киназы tie-2 | |
| RU2007144530A (ru) | Применение производных пиримидиламинобензамида для лечения системного мастоцитоза | |
| RU2011140404A (ru) | Применение производных пиримидиламинобензамида для лечения нарушений, опосредованных киназой, содержащей мотив лейциновой "молнии" и стерильный альфа мотив (zak) | |
| HRP20100265T1 (hr) | Smjesa od pirimidilaminobenzamid spojeva i imatiniba za liječenje ili prevenciju proliferativnih bolesti |